Topic:

Partnering

Latest Headlines

Latest Headlines

AliveCor teams with India's Apollo Hospitals to offer smartphone heart monitoring

AliveCor, the maker of the first FDA-approved smartphone-based device to detect atrial fibrillation, is partnering with Apollo Hospitals to provide the monitor to patients throughout India.

Harvard gets DARPA grant to develop soft, mobility exosuit

The Defense Advanced Research Projects Agency awarded Harvard University engineers up to $2.9 billion to develop a robotic suit to make walking easier for soldiers and potentially civilians with disabilities, the university announced today.

Blackberry to integrate medical devices in India

Blackberry is launching an ambitious project to integrate thousands of medical devices in India in order to detect illnesses earlier. 

Genmab re-ups with Seattle Genetics on a $211M armed antibody cancer drug pact

Genmab is taking its cancer drug collaboration with Seattle Genetics one more step forward. The Danish biotech is handing over an $11 million upfront and promising up to $200 million more to get the right to use Seattle Genetics' antibody-drug conjugate technology for its HuMax-AXL program.

Ophthotech wins a $50M milestone from Novartis

Ophthotech says it won a $50 million enrollment milestone from Novartis for reaching a goal on its Phase III Fovista study for wet, age-related macular degeneration.

Merck KGaA dives into allergy R&D with platform pact

Facing dwindling sales and a thin late-stage pipeline, Merck KGaA is looking to accelerate its efforts in allergy drug development, signing a deal with an Austrian biotech with hopes of quickly seeding new programs in the field.

J&J teams with Bavarian Nordic on an emergency Ebola vaccine program

The deadly outbreak of Ebola in West Africa is pushing related vaccine and drug development efforts from first gear into overdrive. Today it's J&J's turn to step up, teaming with the Danish biotech Bavarian Nordic to pair up vaccine components into a new jab with the help of the National Institute of Allergy and Infectious Diseases. And the pharma giant says it can start testing the new combination vaccine in a rushed clinical trial slated to start in early 2015.

UPDATED: AbbVie partners with Google's Calico on $1.5B R&D operation focused on aging

Hot on the heels of its $805 million development deal with Infinity, AbbVie Pharmaceuticals has followed up today with a plan to partner with Google's closely watched biotech upstart Calico on a new research operation that will cost up to $1.5 billion to get started.

BioTime enters academic collaborations to advance its hydrogel for vocal fold scarring

BioTime is entering into a partnership with the University of Wisconsin and Belgium's Louvain University to develop the company's hydrogel-based treatment for vocal fold scarring.

AbbVie ties the knot with Infinity in $805M blood cancer collaboration

AbbVie has agreed to hand over $275 million upfront to Infinity Pharmaceuticals in exchange for rights to develop and commercialize duvelisib, its oral PI3k-delta/gamma inhibitor for blood cancers. And the blockbuster-size deal for Infinity's lead program comes with $530 million in potential milestones.